ICU Medical Inc (ICUI) stock
ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3034% above fair value
$179.27+1.97 (+1.11%)
Close on Nov 13, 2026Market cap $4.48BP/E 74.4Yield –
ICU Medical total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
ICU Medical's total debt was $1.15B at Sep 30, 2026. For fiscal 2025 it was $1.28B, down 18.8% from the year before. The highest annual figure on record is $1.65B in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.28B | -18.8% |
| FY2024 | Dec 31, 2024 | $1.58B | -2.8% |
| FY2023 | Dec 31, 2023 | $1.63B | -1.5% |
| FY2022 | Dec 31, 2022 | $1.65B | – |
| FY2021 | Dec 31, 2021 | $0 | – |
| FY2019 | Dec 31, 2019 | $0 | – |
| FY2016 | Dec 31, 2016 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.15B | -12.3% |
| Q2 FY2026 | Jun 30, 2026 | $1.23B | -8.0% |
| Q1 FY2026 | Mar 31, 2026 | $1.28B | -16.6% |
| Q4 FY2025 | Dec 31, 2025 | $1.28B | -18.8% |
| Q3 FY2025 | Sep 30, 2025 | $1.31B | -17.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.34B | -16.7% |
| Q1 FY2025 | Mar 31, 2025 | $1.54B | -5.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.58B | -2.8% |
| Q3 FY2024 | Sep 30, 2024 | $1.59B | -2.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.61B | -2.1% |
| Q1 FY2024 | Mar 31, 2024 | $1.62B | -1.8% |
| Q4 FY2023 | Dec 31, 2023 | $1.63B | -1.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.63B | -1.2% |
| Q2 FY2023 | Jun 30, 2023 | $1.64B | -0.8% |
| Q1 FY2023 | Mar 31, 2023 | $1.65B | -0.5% |
| Q4 FY2022 | Dec 31, 2022 | $1.65B | – |
| Q3 FY2022 | Sep 30, 2022 | $1.65B | +1002.8% |
| Q2 FY2022 | Jun 30, 2022 | $1.66B | +1003.4% |
| Q1 FY2022 | Mar 31, 2022 | $1.66B | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q2 FY2020 | Jun 30, 2020 | $150.00M | +100.0% |
| Q1 FY2020 | Mar 31, 2020 | $150.00M | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2017 | Sep 30, 2017 | $75.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $75.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $0 | – |
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
See a number that looks wrong?